Jared J. Grantham

Jared J. Grantham's AcademicInfluence.com Rankings

Jared J. Grantham

Philosophy

#5048

World Rank

#7760

Historical Rank

Logic

#2390

World Rank

#3374

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jared J. Grantham's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Jared J. Grantham Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jared J. Grantham's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tolvaptan in patients with autosomal dominant polycystic kidney disease. (2012) (1190)
Preparation and study of fragments of single rabbit nephrons. (1966) (784)
Clinical practice. Autosomal dominant polycystic kidney disease. (2008) (435)
Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3',5'-monophosphate, and theophylline. (1968) (426)
Effect of vasopressin and cyclic AMP on permeability of isolated collecting tubules. (1966) (421)
Blood pressure in early autosomal dominant polycystic kidney disease. (2014) (389)
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. (2015) (378)
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. (2007) (377)
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. (2003) (364)
Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype* (2004) (338)
cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. (2000) (330)
Cyst formation and growth in autosomal dominant polycystic kidney disease. (1987) (318)
Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. (2003) (316)
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. (2012) (307)
Volume progression in polycystic kidney disease. (2006) (280)
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. (2005) (275)
Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. (2005) (271)
Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. (2004) (265)
Why kidneys fail in autosomal dominant polycystic kidney disease (2011) (229)
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. (2006) (229)
Angiotensin blockade in late autosomal dominant polycystic kidney disease. (2014) (223)
The nature of transtubular Na and K transport in isolated rabbit renal collecting tubules. (1970) (213)
Morbidity and Mortality of Renal Dialysis: An NIH Consensus Conference Statement (1994) (205)
Epithelial transport in polycystic kidney disease. (1998) (199)
Physical properties of isolated perfused renal tubules and tubular basement membranes. (1972) (193)
The genetics and physiology of polycystic kidney disease. (2001) (173)
Polycystic kidney disease: neoplasia in disguise. (1990) (164)
Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. (1989) (160)
ULTRASTRUCTURAL STUDIES OF VASOPRESSIN EFFECT ON ISOLATED PERFUSED RENAL COLLECTING TUBULES OF THE RABBIT (1968) (159)
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience. (2011) (159)
A hereditary model of slowly progressive polycystic kidney disease in the mouse. (1991) (152)
The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. (1996) (150)
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. (2006) (147)
Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. (1987) (143)
The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. (1996) (141)
The kidney: from normal development to congenital disease (2003) (138)
Ultrastructure and function of cysts from human adult polycystic kidneys. (1980) (137)
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. (2011) (134)
A case for water in the treatment of polycystic kidney disease. (2009) (131)
1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. (1993) (130)
A clinical index to predict survival in acute renal failure patients requiring dialysis. (1988) (130)
Effect of vasopressin on electrical resistance of renal cortical collecting tubules. (1971) (130)
Isovolumetric regulation of isolated S2 proximal tubules in anisotonic media. (1986) (128)
Polycystic kidney disease: etiology, pathogenesis, and treatment. (1995) (127)
Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. (2016) (127)
Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP (1989) (126)
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. (2008) (125)
Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. (1997) (124)
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. (2011) (123)
Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. (1991) (122)
Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. (2002) (121)
Acquired cystic disease: replacing one kidney disease with another. (1985) (120)
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial. (2016) (119)
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). (2005) (119)
Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease. (2003) (118)
Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation. (2006) (118)
Regulation of renal tubule cell volume in hypotonic media. (1973) (116)
PATHS OF TRANSTUBULAR WATER FLOW IN ISOLATED RENAL COLLECTING TUBULES (1969) (115)
Chloride and fluid secretion by cultured human polycystic kidney cells. (1996) (114)
CT of acquired cystic kidney disease and renal tumors in long-term dialysis patients. (1984) (112)
Macropuncture study of polycystic disease in adult human kidneys. (1980) (110)
The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. (1993) (109)
Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells. (1996) (104)
The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. (2002) (102)
Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study. (1991) (100)
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. (2003) (99)
In vitro fluid secretion by epithelium from polycystic kidneys. (1995) (98)
Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. (2003) (97)
Chloride and fluid secretion in polycystic kidney disease. (1998) (97)
Liver cysts in autosomal-dominant polycystic kidney disease: clinical and computed tomographic study. (1985) (97)
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. (2015) (97)
Chemical modification of cell proliferation and fluid secretion in renal cysts. (1989) (96)
Mechanisms of progression in autosomal dominant polycystic kidney disease. (1997) (95)
Polycystic kidney disease: a predominance of giant nephrons. (1983) (95)
Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. (1995) (95)
In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. (1992) (95)
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort. (2006) (94)
A comparison of ultrasound and magnetic resonance imaging shows kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease (2015) (94)
The importance of total kidney volume in evaluating progression of polycystic kidney disease (2016) (94)
Autosomal recessive polycystic kidney disease in a murine model. A gross and microscopic description. (1988) (93)
Acquired cystic kidney disease. (1991) (93)
Determinants of renal volume in autosomal-dominant polycystic kidney disease. (2008) (90)
Imaging for the prognosis of autosomal dominant polycystic kidney disease (2010) (87)
The medicinal use of water in renal disease. (2013) (85)
Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents. (1995) (83)
Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach. (2003) (82)
Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. (2000) (81)
Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. (1992) (78)
Water prescription in autosomal dominant polycystic kidney disease: a pilot study. (2011) (77)
Disturbances in body fluid osmolality (1977) (76)
Vanadate-stimulated natriuresis (1978) (74)
Electrical properties of isolated perfused rabbit renal tubules. (1968) (73)
Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells. (1995) (71)
Return of the secretory kidney. (2002) (70)
The role of computed tomography in the evaluation of adult polycystic kidney disease. (1981) (68)
Net fluid secretion in proximal straight renal tubules in vitro: role of PAH. (1974) (68)
Evidence of extraordinary growth in the progressive enlargement of renal cysts. (2010) (68)
Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study (2013) (67)
Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse. (1992) (66)
MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. (2009) (66)
Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease (2017) (65)
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. (2017) (65)
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. (2017) (64)
Influence of serum proteins on net fluid reabsorption of isolated proximal tubules. (1972) (63)
Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. (2001) (61)
Effect of hypotonic medium on K and Na content of proximal renal tubules. (1977) (61)
Exacerbation of familial renal lymphangiomatosis during pregnancy. (1988) (61)
Sequential protooncogene expression in regenerating kidney following acute renal injury. (1989) (59)
Evaluation of urine biomarkers of kidney injury in Polycystic Kidney Disease (2012) (58)
Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules. (1996) (57)
Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid (2004) (57)
A synthetic channel-forming peptide induces Cl(-) secretion: modulation by Ca(2+)-dependent K(+) channels. (2000) (57)
Fluid secretion in isolated proximal straight renal tubules. Effect of human uremic serum. (1973) (57)
Novel Approach to Estimate Kidney and Cyst Volumes Using Mid-Slice Magnetic Resonance Images in Polycystic Kidney Disease (2013) (54)
Modification of disease progression in rats with inherited polycystic kidney disease. (1996) (53)
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD) (2018) (52)
Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. (1992) (51)
cAMP-dependent fluid secretion in rat inner medullary collecting ducts. (2001) (51)
Rationale for early treatment of polycystic kidney disease (2015) (51)
PH-dependent accumulation of clindamycin in a polycystic kidney. (1983) (50)
Identification of a forskolin-like molecule in human renal cysts. (2007) (50)
Tubular basement membrane changes in 2-amino-4,5-diphenylthiazole-induced polycystic disease. (1985) (50)
Vasopressin: Effect on Deformability of Urinary Surface of Collecting Duct Cells (1970) (50)
Basis for heterogeneity of para-aminohippurate secretion in rabbit proximal tubules. (1981) (49)
Viscoelastic properties of tubule basement membranes in experimental renal cystic disease. (1987) (48)
Polycystic kidney disease: from the bedside to the gene and back (2001) (47)
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease. (2013) (46)
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial. (2016) (46)
The transport and accumulation of oxyvanadium compounds in human erythrocytes in vitro. (1982) (45)
The effects of vanadate on the fluxes of sodium and potassium ions through the sodium pump (1980) (44)
Long-term effect of uninephrectomy on serum creatinine concentration and arterial blood pressure. (1985) (44)
The renal sodium pump and vanadate. (1980) (44)
Spontaneous subcapsular and perinephric hemorrhage in end-stage kidney disease: clinical and CT findings. (1987) (43)
A synthetic peptide derived from glycine-gated Cl- channel induces transepithelial Cl- and fluid secretion. (1997) (43)
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease. (2019) (43)
Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. (2017) (43)
Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts. (2013) (42)
C‐Fos expression is hypersensitive to serum‐stimulation in cultured cystic kidney cells from the C57BL/6J‐cpk mouse (1992) (42)
High-density renal cysts in autosomal dominant polycystic kidney disease demonstrated by CT. (1985) (40)
Cellular aspects of renal sodium transport and cell volume regulation. (1976) (40)
Electrolyte and fluid secretion by cultured human inner medullary collecting duct cells. (2002) (39)
Understanding human cystic disease through experimental models. (1991) (39)
Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease. (2005) (38)
Tubular obstruction leads to progressive proximal tubular injury and atubular glomeruli in polycystic kidney disease. (2014) (37)
Residual renal function: a paradigm shift. (2017) (37)
Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease. (1995) (37)
The effect of hyponatremia on the regulation of intracellular volume and solute composition. (1984) (36)
The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees. (2015) (35)
Detected renal cysts are tips of the iceberg in adults with ADPKD. (2012) (35)
Fluorescein transport in isolated proximal tubules in vitro: epifluorometric analysis. (1990) (35)
Renal Na,K-ATPase: determinants of inhibition by vanadium. (1979) (33)
Arginine vasopressin stimulates net fluid secretion in a polarized subculture of cyst-forming MDCK cells. (1991) (32)
Time to treat polycystic kidney diseases like the neoplastic disorders that they are. (2000) (31)
Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. (2004) (31)
Pathogenesis of renal cyst expansion: opportunities for therapy. (1994) (31)
Effect of Prostaglandin E1 on the Permeability Response of the Isolated Collecting Tubule to Vasopressin (1968) (30)
Effect of collagenase and ouabain on renal cell volume in hypotonic media. (1980) (30)
Specificity of basolateral organic anion exchanger in proximal tubule for cellular and extracellular solutes. (1992) (30)
The rebirth of interest in renal tubular function. (2016) (30)
Therapy for polycystic kidney disease? It's water, stupid! (2008) (29)
Studies of organic anion and cation transport in isolated segments of proximal tubules. (1982) (29)
DIRECT OBSERVATION OF TOAD BLADDER RESPONSE TO VASOPRESSIN (1971) (28)
Studies of isolated renal tubules in vitro. (1978) (28)
Temperature effect on ADH response of isolated perfused rabbit collecting tubules. (1980) (28)
Cyst fluid from a murine model of polycystic kidney disease stimulates fluid secretion, cyclic adenosine monophosphate accumulation, and cell proliferation by Madin-Darby canine kidney cells in vitro. (1995) (27)
Fluid secretion in the nephron: Relation to renal failure. (1976) (27)
A method to measure the rate of net fluid secretion by monolayers of cultured renal epithelial cells (1991) (26)
INTRACELLULAR PH AND BUFFERING CAPACITY OF THE WALKER-256 CARCINOMA. (1965) (26)
Renal excretion and cyst accumulation of beta 2microglobulin in polycystic kidney disease. (1987) (25)
Coupling of cell volume and membrane potential changes to fluid secretion in a model of renal cysts. (1994) (25)
Carbon dioxide dissociation curve in potassium depletion. (1967) (25)
Effect of probucol in a murine model of slowly progressive polycystic kidney disease. (2000) (24)
The effect of paclitaxel on the progression of polycystic kidney disease in rodents. (1997) (24)
Polycystic kidney disease (1996) (23)
The renal response to intravenous vanadate in rats. (1980) (23)
Mechanisms of fluid secretion by polycystic epithelia. (1996) (23)
ASYMPTOMATIC HYPONATREMIA AND BRONCHOGENIC CARCINOMA: THE DELETERIOUS EFFECTS OF DIURETICS (1965) (23)
Diet and polycystic kidney disease: A pilot intervention study. (2017) (22)
Perinephric hemorrhage in autosomal dominant polycystic kidney disease: CT and MR findings. (1987) (22)
Transepithelial water permeability in an in vitro model of renal cysts. (1990) (22)
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease (2016) (22)
Sulfonylurea-sensitive K(+) transport is involved in Cl(-) secretion and cyst trowth by cultured ADPKD cells. (2002) (22)
Urinary lipid bodies in polycystic kidney disease. (1985) (21)
Polycystic kidney disease--an old problem in a new context. (1988) (21)
Renal pain in polycystic kidney disease: when the hurt won't stop. (1992) (20)
Preparation of renal papillary collecting duct cells for study in vitro. (1975) (19)
Explant culture of human polycystic kidney. (1988) (19)
Effective use of streptokinase for peritoneal catheter failure. (1985) (19)
Pathogenesis of autosomal dominant polycystic kidney disease: recent developments. (1997) (19)
INTERRELATION OF POTASSIUM AND HYDROGEN ION GRADIENTS IN METABOLIC ALKALOSIS. (1965) (19)
Effect of basement membrane and colloid osmotic pressure on renal tubule cell volume. (1977) (19)
Renal cell proliferation and the two faces of cyclic adenosine monophosphate. (1997) (19)
Rabbit tubular basement membrane. Isolation and analysis of polypeptides. (1979) (18)
Polycystic kidney disease: In danger of being X-rated? (2001) (18)
Net fluid secretion by mammalian renal epithelial cells: stimulation by cAMP in polarized cultures derived from established renal cells and from normal and polycystic kidneys. (1989) (18)
Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man. (1975) (18)
Polycystic kidney disease: I. Etiology and pathogenesis. (1992) (18)
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials. (2018) (18)
Polycystic kidney disease: hereditary and acquired. (1993) (18)
Polycystic kidney disease--there goes the neighborhood. (1995) (16)
Morbidity and mortality of renal dialysis (1994) (16)
Acute magnesium depletion and excess induced by hemodialysis. (1960) (15)
Volume regulation determinants in isolated proximal tubules in hypertonic medium. (1989) (15)
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. (2017) (15)
Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease. (1997) (14)
Prognosis for recovery of function in acute renal failure. Value of the renal image obtained using iodohippurate sodium I 131. (1976) (14)
Novel Methodology to Evaluate Renal Cysts in Polycystic Kidney Disease (2014) (14)
mTOR inhibitors and autosomal dominant polycystic kidney disease. (2011) (13)
ACUTE SUBTRACTION ALKALOSIS FROM GASTRIC JUICE LOSS IN DOGS. (1964) (13)
Acquired Cystic Disease: Replacing One Kidney Disease With Another (1986) (13)
Effect of amiloride on the compensatory renal growth that follows uninephrectomy in mice. (1989) (13)
Letter: Hyperacute rejection of renal allografts following pulsatile perfusion with a perfusate containing specific antibody. (1974) (12)
Characterization of the collagenous domain of tubular basement membrane. (1981) (11)
Transmembrane electrical potential differences in cells of isolated renal tubules. (1981) (11)
Percutaneous transluminal angioplasty in transplant renal artery stenosis: experience and review of the literature. (1986) (10)
Uremia: Strategies in the Search for Toxins (1978) (10)
Management of Renal Cystic Disorders (1984) (10)
Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease (2020) (9)
Effect of cellular acidosis on cell volume in S2 segments of renal proximal tubules. (1990) (9)
TOXICITY REVERSED: REVERSAL OF IMIPRAMINE-MONOAMINE OXIDASE INHIBITOR INDUCED TOXICITY BY CHLORPROMAZINE. (1964) (9)
Solitary renal cysts: worth a second look? (2012) (9)
Radiology of Cystic Kidneys (1990) (8)
Marshall Barber and the origins of micropipette methods. (1982) (8)
Proximal tubule volume regulation in hypo-osmotic media: intracellular K+, Na+, and Cl-. (1990) (7)
INTRACELLULAR PH MEASUREMENT WITH TRITIATED WATER, CARBON-14 LABELED 5,5-DIMETHYL-2, 4-OXAZOLIDINEDIONE, AND CHLORIDE-36. (1965) (7)
Mode of water transport in mammalian renal collecting tubules. (1971) (7)
Polycystic kidney disease: huge kidneys, huge problems, huge progress. (1997) (7)
The Use of the Isolated Tubule Preparation for the Investigation of Diuretics (1976) (7)
Experiences and Perspectives of Polycystic Kidney Disease Patients following a Diet of Reduced Osmoles, Protein, and Acid Precursors Supplemented with Water: A Qualitative Study (2016) (7)
Cellular electrolyte and volume changes induced by acidosis in the rabbit proximal straight tubule. (1991) (7)
Clinical aspects of adult and infantile polycystic kidney disease. (1985) (6)
Effect of vanadate on fluid absorption and PAH secretion in isolated proximal tubules. (1983) (6)
CRISP: opening a new frontier in the diagnosis and treatment of PKD. (2006) (6)
Regulation of cell proliferation and fluid secretion in the progressive enlargement of renal cysts. (1992) (6)
Dependence of proximal tubule p-aminohippurate secretion on serum proteins and metabolic substrates. (1986) (5)
ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing. (2018) (5)
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease (2021) (5)
The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context. (2002) (5)
Epidermal growth factor promotes cyst formation by human renal epithelial cells in vitro. (1990) (4)
The Birth and Early Development of JASN. (2010) (4)
Refractory hypercalcemia. Management with intravenous fluids and furosemide guided by Swan-Ganz monitoring. (1983) (4)
Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease. (2017) (4)
Lysine methyltransferase SMYD 2 promotes cyst growth in autosomal dominant polycystic kidney disease (2019) (4)
Does extended-release somatostatin slow the growth of renal cysts in autosomal-dominant polycystic kidney disease? (2006) (4)
Preparation and study of fragments of single rabbit nephrons. (1997) (4)
Renal preservation with Plasmanate-albumin perfusate: successful clinical use. (1974) (4)
Disseminated intravascular coagulation. Postpartum hemolytic-uremic syndrome with recovery of renal function. (1971) (4)
Inhibition of vasopressin action by vanadate in the cortical collecting tubule. (1983) (4)
The inscrutable renal cyst in ADPKD. (1995) (3)
ADPKD - CLINICAL OUTCOME STUDIES (2014) (3)
BIDIRECTIONAL FLUID TRANSPORT IN THE PROXIMAL TUBULE (1982) (3)
Profound pharmacologic inhibition of renal tubule sodium and water reabsorption in rats. (1985) (3)
Fast Track Cyst Number but Not the Rate of Cystic Growth Is Associated with the Mutated Gene in Autosomal Dominant Polycystic Kidney Disease (2006) (3)
Evidence for an inhibitor of renal urate and PAH secretion in rabbit blood. (1983) (3)
Forefronts in Nephrology: The molecular basis of renal cystic disease (1995) (3)
Pathogenesis of renal cysts in dominantly inherited polycystic kidney disease. (1995) (3)
Randomised Controlled Trial to Determine the Efficacy of Prescribed Fluid Intake to Reduce Progression in Adpkd (Prevent-Adpkd) (2016) (3)
Ethical issues and genetic counselling. (1995) (2)
Tubule urate and PAH transport: sensitivity and specificity of serum protein inhibition. (1987) (2)
MEASUREMENT OF INTRACELLULAR HYDROGEN ION CONCENTRATION IN PATIENTS. (1964) (2)
Natriuretic hormones: at last, bottled in bond? (1984) (2)
Characteristics of renal p-aminohippurate and urate excretion in rabbits. (1986) (2)
Renal Cystic Disease (1998) (2)
BODY COMPOSITION AND PLASMA CONCENTRATIONS IN GASTRIC ALKALOSIS * (1963) (2)
Movements of Salts and Water into Cysts in Polycystic Kidney Disease (1985) (2)
Segmentation and volumetric measurement of renal cysts and parenchyma from MR images of polycystic kidneys using multi-spectral analysis method (2008) (2)
Correction: Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study (2013) (2)
Progression in Polycystic Kidney Disease (2006) (2)
Renal Cystic Disorders (1991) (2)
Control of Renal Cyst Formation and Enlargement (1991) (2)
INTRACELLULAR PH AND MUSCLE ELECTROLYTES IN METABOLIC ALKALOSIS FROM LOSS OF GASTRIC JUICE. (1964) (2)
Evaluation of Function in Single Segments of Isolated Renal Blood Vessels, Nephrons, and Collecting Ducts (2011) (1)
Inorganic Ions and Volume Regulation in Kidney Tubules Under Anisosmotic Conditions (1991) (1)
Cell Volume Regulation in Epithelia (1984) (1)
Comparison of the chemical and polypeptide composition of tubular and glomerular basement membranes. (1980) (1)
RENAL DEVELOPMENT AND CYSTIC DISEASES (2013) (0)
Nephrology on the rise. (1990) (0)
Effect of vanadate on organ systems (1986) (0)
Renal transplantation. Complications and outcome. (1973) (0)
Significance of comparative studies for renal physiology (1980) (0)
Cystic Disease of the Kidney: Clinical and Pathophysiologic Aspects (1991) (0)
Water induced natriuresis and atrial natriuretic factor secretion in healthy humans: modulation by the sodium intake (1989) (0)
Renal pain in polycystic kidney disease (1992) (0)
Renal transplantation. A decade of experience. (1979) (0)
A gift of life: kidney retrieval. (1975) (0)
JASN's Silver Jubilee. (2015) (0)
Erratum: Approaches to testing new treatments in autosomal dominant polycystic kidney disease: Insights from the CRISP and HALT-PKD studies (Clinical Journal of the American Society and Nephrology (2008) vol. 3 (1197-1204)) (2008) (0)
Consultant List (2002) (0)
The single nephron preparation--cortical collecting tubules. (1972) (0)
Involvement of atrial natriuretic factor and natriuresis in the volume adjustment to acute water intake in man (1990) (0)
Similarity of the dialysance of endogenous aryl acids and O-iodohippurate (hippuran) in uremic man. (1974) (0)
Contents, Vol. 3, 1980 (1980) (0)
Autosomal Dominant Polycystic Kidney Disease (2008) (0)
Bully renal cysts knock down urine-concentrating capacity in the early rounds. (2012) (0)
Nephrology. Pattern of consultation in a general hospital. (1974) (0)
Evolution of the Kidney Research Program at the University of Kansas Medical Center (2000) (0)
Performance of the Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in a longitudinal study of Autosomal Dominant Polycystic Kidney Disease (2017) (0)
The Use of Isolated Tubules in the Study of Regulation of Cell Volume (1981) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jared J. Grantham?

Jared J. Grantham is affiliated with the following schools: